Chalfont St Giles, UK and Philadelphia, PA – General Electric and MDS Pharma Services announced the availability of a new, automated in vitro micronucleus assay that incorporates GE Healthcare’s IN Cell 1000 and IN Cell 3000 high content analysis platforms. This automated imaging assay enables an accurate, early assessment of the potential genotoxicity of novel […]
PALO ALTO, Calif., — Cell Biosciences announces the introduction of the Firefly(TM) 3000 automated blotless immunoassay workstation for quantitative measurement of cell signaling and protein expression. The Firefly system is designed to leverage the knowledge and intuition of life science researchers by introducing automated parallel analysis into their laboratory operations. The heart of the Firefly […]
PITTSBURGH, Pa., and HAMBURG, Germany,– Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH announced today that they have entered into a worldwide, non-exclusive patent license agreement. The agreement will provide Evotec Technologies with Cellomics’ core High Content Screening (HCS) patent portfolio, which includes both broad claims to HCS technology […]
Seattle, WA and Carlsbad, CA- Invitrogen has agreed to acquire Xcyte Therapies’ cell expansion technology, including intellectual property, clinical data, raw materials and equipment, for $5 million in cash. In addition, Xcyte will also be entitled to a percentage of sublicensing revenue related to the intellectual property for therapeutic applications. “To Invitrogen, this transaction represents […]
Gothenburg, Sweden — Cellectricon today announced the launch of the new CellaxessTM CX1 and CX3 Systems for adherent cell electroporation based on Cellectricon’s patented (U.S. Patent #6,521,430) capillary electroporation technology. The technology provides new possibilities for hard-to-transfect cells. Developed for life scientists, Cellaxess offers novel transfection capabilities based on patented and revolutionary capillary electroporation technology. […]
Gothenburg, Sweden: Cellectricon today announced the launch of the new Dynaflow (TM) Pro II System for safety pharmacology studies. The system comes with the newly developed DF-8 Pro II Chip successfully beta-tested for conducting GLP hERG studies by Swiss ion channel CRO bSys GmbH. Developed for life scientists and drug discovery researchers, the Dynaflow System […]
WASHINGTON, DC – Today at the Society of Neuroscience meeting in Washington, D.C., GE Healthcare launched Ad-A-Gene Vectors, a large range of ready-to-use, validated adenoviral vector gene delivery reagents. The reagents expand the possibilities for lead compound profiling, drug target validation and basic research by enabling the rapid development of transient cell signaling assays. The […]
Fullerton, California, – Beckman Coulter, Inc. introduces Cell Lab Quanta SC – the second offering in its new family of affordable flow cytometers for drug discovery and basic clinical research. The Quanta SC combines side light scatter detection and a third fluorescent channel with Coulter volume measurement to deliver accurate, multiparameter cell counting and sizing. […]
Pay Invoice
Latest Blogs
-
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
